Rebecca M. Burke, Ph.D. - Publications
Affiliations: | 2012 | Pharmacology and Experimental Therapeutics | Boston University, Boston, MA, United States |
Area:
NeuroscienceYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Mellott TJ, Pender SM, Burke RM, Langley EA, Blusztajn JK. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice. Plos One. 9: e94287. PMID 24732467 DOI: 10.1371/Journal.Pone.0094287 | 0.454 | |||
2013 | Burke RM, Norman TA, Haydar TF, Slack BE, Leeman SE, Blusztajn JK, Mellott TJ. BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 19567-72. PMID 24218590 DOI: 10.1073/Pnas.1319297110 | 0.352 | |||
Show low-probability matches. |